Peter Smith is Professor of Tropical Epidemiology at the London School of Hygiene &Tropical Medicine (LSHTM). He graduated in mathematics and statistics from City University, London and in 1965 joined the Medical Research Council’s Statistical Research Unit in London. Since then he has worked on various aspects of epidemiological and statistical research in: the MRC Clinical and Population Cytogenetics Research Unit, Edinburgh (1967-69); Makerere University Medical School, Uganda (1970-71); the International Agency for Research on Cancer, Lyon, France and Uganda (1971-72); the Imperial Cancer Research Fund Cancer Epidemiology Unit, Oxford (1972-79); Harvard School of Public Health, Boston (1987); and the Tropical Diseases Research Programme of WHO (1987). He joined LSHTM in 1979 to head the Tropical Epidemiology Unit. Research interests include large-scale intervention studies against tropical diseases, including vaccine trials. From 1999 to 2004 he chaired the UK Government Advisory Committee on Bovine Spongiform Encephalopathy (BSE) and variant Creutzfeldt-Jakob Disease in humans. Up to 2011 he chaired the WHO Global Advisory Committee on Vaccine Safety and chaired the WHO Global Malaria Programme/Initiative for Vaccine Research Joint Technical Expert Group (JTEG) on Malaria Vaccines in Pivotal Phase 3 Trials & Beyond. He has served on the Scientific Advisory Board of the International Vaccine Institute in Korea and the Board of Management of the Medicines for Malaria Venture. He has served as the Deputy Chair of the Nuffield Council on Bioethics and from 2004 to 2014 was a Governor of the Wellcome Trust. He is currently on the Scientific Advisory Committees of the Coalition for Epidemic Preparedness Innovations (CEPI), the European and Developing Countries Clinical Trials Partnership (EDCTP) and serves on the WHO SAGE Working Group on COVID-19 vaccines. He chairs the Programme Advisory Group for the WHO Malaria Vaccine Implementation Pilots (for the RTSS/AS01 vaccine).